Showing 20,441 - 20,460 results of 30,146 for search '(( significantly ((better decrease) OR (year increase)) ) OR ( significant decrease decrease ))', query time: 0.78s Refine Results
  1. 20441

    Data Sheet 1_Associations between self-reported sleep duration and incident cardiovascular diseases in a nationwide prospective cohort study of Chinese middle-aged and older adults... by Qing Zhao (170569)

    Published 2024
    “…</p>Results<p>Over the 8-year follow-up, 2,359 CVD events were recorded. Compared to individuals sleeping 6–8 h per day, a short sleep duration (≤6 h/day) was significantly associated with an increased risk of CVD (HR: 1.17, 95% CI: 1.03–1.33). …”
  2. 20442

    Image 1_APE1 mediates chemoresistance in esophageal squamous cell carcinoma by remodeling the immunosuppressive microenvironment.pdf by Han Gao (486886)

    Published 2025
    “…The high-expression group had significantly worse 5-year OS (27% vs. 91.4%) and DFS (14.3% vs. 55.3%) than the low-expression group (p<0.001), confirmed in public databases. …”
  3. 20443

    <b>A Wave in Pediatric Type 1 Diabetes Incidence after the Emergence of COVID-19: Peak and Trough Patterns in German Youth - A Population-Based Study from the Prospective Multicent... by Clemens Kamrath (846872)

    Published 2025
    “…<p dir="ltr">The incidence of type 1 diabetes (T1D) in children increased significantly during the COVID-19 pandemic (1,2). …”
  4. 20444

    Data Sheet 1_The association of polypharmacy with intrinsic capacity: an analysis of the WHO ICOPE pilot data from Lianyungang, China.docx by Xia Yun (5983241)

    Published 2025
    “…However, in the fully adjusted Model 4 (including comorbidities), the OR attenuated to 2.31 (95% CI: 0.77–6.88, p = 0.134), retaining a positive but non-significant association. After full covariate adjustment, each additional medication was associated with a 22% increase in the likelihood of IC decline (OR = 1.22, 95% CI: 1.01–1.47, p = 0.04). …”
  5. 20445

    Included studies basic characteristics. by Xuqin Du (8803772)

    Published 2025
    “…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
  6. 20446

    Forest plot for FVC. by Xuqin Du (8803772)

    Published 2025
    “…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
  7. 20447

    DataSheet1_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review... by Xuqin Du (8803772)

    Published 2024
    “…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO<sub>2</sub> (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO<sub>2</sub> (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”
  8. 20448

    DataSheet2_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review... by Xuqin Du (8803772)

    Published 2024
    “…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO<sub>2</sub> (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO<sub>2</sub> (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”
  9. 20449

    All data extracted. by Xuqin Du (8803772)

    Published 2025
    “…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
  10. 20450

    Table1_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review and... by Xuqin Du (8803772)

    Published 2024
    “…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO<sub>2</sub> (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO<sub>2</sub> (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”
  11. 20451

    Forest plot for TNF- by Xuqin Du (8803772)

    Published 2025
    “…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
  12. 20452

    Table 3_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

    Published 2025
    “…</p>Results<p>Over the period 2015–2023 in Quzhou, life expectancy increased by 1.55 years. Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”
  13. 20453

    Table 5_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

    Published 2025
    “…</p>Results<p>Over the period 2015–2023 in Quzhou, life expectancy increased by 1.55 years. Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”
  14. 20454

    Table 2_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

    Published 2025
    “…</p>Results<p>Over the period 2015–2023 in Quzhou, life expectancy increased by 1.55 years. Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”
  15. 20455

    Table 1_Association between oxidative balance score and methylation cycle biomarkers in US adults: insights from the national health and nutrition examination survey.docx by Xuna Liu (16988607)

    Published 2025
    “…Additionally, the negative correlation between OBS and MMA was observed in the elderly population (≥ 60 years old) when stratified by age. RCS regression analysis revealed that with the increase in OBS, serum folate, RBC folate, vitamin B6, and vitamin B12 also increased, while HCY and MMA decreased.…”
  16. 20456

    Table 1_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

    Published 2025
    “…</p>Results<p>Over the period 2015–2023 in Quzhou, life expectancy increased by 1.55 years. Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”
  17. 20457

    Image 1_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.jpeg by Jie Pan (187977)

    Published 2025
    “…</p>Results<p>Over the period 2015–2023 in Quzhou, life expectancy increased by 1.55 years. Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”
  18. 20458

    Table 4_Unraveling life expectancy and death spectrum changes of registered residents (hukou) in Quzhou, China, 2015–2023: a study using Arriaga decomposition method.docx by Jie Pan (187977)

    Published 2025
    “…</p>Results<p>Over the period 2015–2023 in Quzhou, life expectancy increased by 1.55 years. Age groups 55–80 made significant positive contributions, while 0- and 85- groups saw decreased contributions. …”
  19. 20459
  20. 20460